DarioHealth

DRIO62

Penny Stock

$0.99arrow_drop_up11.10%$0.09

Penny Stock

DRIO62

$0.99

arrow_drop_up11.10%$0.09

Penny Stock

Performance History

Key Stats
Open	$0.91
Prev. Close	$0.90
EPS	-1.17
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$26.24M
PE Ratio	-

	LOW	HIGH
Day Range	0.91	0.91
52 Week Range	0.68	3.49

Ratios







EPS	-1.17

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About DarioHealth (DRIO)

DarioHealth Corp (DRIO) is a company that is focused on revolutionizing chronic disease management through its innovative digital health solutions. The company's flagship product is the Dario Blood Glucose Monitoring System, which allows people with diabetes to track their blood sugar levels in real-time and make informed decisions about their health. This system combines a compact glucose meter that connects to a smartphone app, enabling seamless monitoring and data analysis. In addition, DarioHealth offers personalized coaching, education, and support to help individuals manage their condition more effectively.

Over the years, DarioHealth Corp has made significant strides in the digital health space. Its stock price history reflects a steady upward trend, with consistent growth and strong performance. The company has positioned itself as a leader in the industry, constantly pushing boundaries and exploring new opportunities to improve patient outcomes. With a market cap of over $100 million, DarioHealth Corp has proven its ability to deliver results and attract investors. Its PEG ratio suggests that the stock is currently undervalued compared to its earnings growth potential, making it an attractive investment opportunity.

Websitecall_made

Sector: Healthcare
Industry: Diagnostics & Research
CEO: Mr. Erez Raphael
Headquarters: New York
Employees: 241
Exchange: NASDAQ

Keep an eye on DarioHealth

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is DarioHealth's (DRIO) price per share?

The current price per share for DarioHealth (DRIO) is $1. The stock has seen a price change of $0.1 recently, indicating a 11.1% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for DarioHealth (DRIO)?

For DarioHealth (DRIO), the 52-week high is $3.49, which is 249.03% from the current price. The 52-week low is $0.68, the current price is 47.04% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is DarioHealth (DRIO) a growth stock?

DarioHealth (DRIO) has shown an average price growth of 0.41% over the past three years. It has received a score of 3 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying DarioHealth as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is DarioHealth (DRIO) stock price performance year to date (YTD)?

As of the latest data, DarioHealth (DRIO) has a year-to-date price change of -40.83%. Over the past month, the stock has experienced a price change of 4.84%. Over the last three months, the change has been -9.1%. Over the past six months, the figure is -33.34%. Looking at a longer horizon, the five-year price change stands at -86.92%.

help

Is DarioHealth (DRIO) a profitable company?

DarioHealth (DRIO) has a net income of -$54.86M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 29.4% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -258.85% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $20.35M, although specific revenue growth data is currently not available. The gross profit is $5.98M. Operating income is noted at -$56.06M. Furthermore, the EBITDA is -$57.96M.

help

What is the market capitalization of DarioHealth (DRIO)?

DarioHealth (DRIO) has a market capitalization of $26.24M. The average daily trading volume is 133.94K, indicating the stock's liquidity and investor engagement.